Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Erenumab Moves Ahead In Treatment-Refractory Migraine in Novartis/Amgen LIBERTY Study
Jan 23 2018
•
By
John Davis
Headache and visual disturbances characterize migraine • Source: Shutterstock
More from Neurological
More from Therapeutic Category